Esposito Pamela

Esposito Pamela is listed in filings as Director at Kymera Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 19, 2026, including sale activity. Recent filings connect the profile to Kymera Therapeutics, Inc. (KYMR). The current snapshot covers public activity from Sep 17, 2024 to May 19, 2026. Reported amounts are shown as $31.2K to $95.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.